How Much Does Apretude Cost in 2026? Price, Insurance, and $0 Pathways

What is Apretude?

Apretude is the brand name for cabotegravir extended-release injectable suspension, manufactured by ViiV Healthcare. FDA-approved in December 2021, it was the first injectable pre-exposure prophylaxis (PrEP) for HIV. It's given as an intramuscular injection every two months after an initial loading phase.

Unlike daily oral PrEP pills, Apretude only requires six injections per year after the loading phase. That convenience factor is why it's increasingly prescribed for people who struggle with daily medication adherence — but the cost profile is dramatically different from generic oral PrEP.

Apretude list price: what the manufacturer charges

ViiV Healthcare sets Apretude's Wholesale Acquisition Cost (WAC — the list price) at approximately $4,038 per 600mg/3mL injection. Because you need six injections a year after loading doses, the annual list-price cost runs roughly $24,000–$24,500.

Apretude list price	What it covers
~$4,038	Per injection (given every 2 months)
~$24,228	Per year, after loading phase
+ admin fees	Clinic charges $50–$200+ per injection visit

On top of the drug cost, your clinic or pharmacy charges an administration fee — typically $50–$200 per injection, depending on whether the injection is billed under a pharmacy benefit or a medical benefit.

But here's the thing: the list price is almost never what anyone actually pays. Between commercial insurance, Medicaid, Medicare, the ViiVConnect copay card, and ViiV's patient assistance program, the vast majority of Apretude users pay $0 out of pocket.

Apretude cost with commercial insurance

If you have private (commercial) insurance through your employer or the ACA marketplace, Apretude is typically covered — but it's usually billed under your medical benefit rather than your pharmacy benefit, because it's administered by a healthcare provider. This distinction matters because medical-benefit drugs are often subject to prior authorization and may apply to your medical deductible before coinsurance kicks in.

The good news: ViiV operates the APRETUDE Savings Program, which typically reduces eligible commercially insured patients' out-of-pocket cost to $0 per injection. The program has an annual maximum (historically around $7,500/year) and is not available to people on government insurance like Medicare or Medicaid.

What you need to know about prior authorization

Because cheap generic oral PrEP exists, insurers frequently require prior authorization before covering Apretude. Your prescriber will typically need to document one or more of the following:

• Documented adherence difficulty on oral PrEP, or
• Clinical reasons oral PrEP isn't appropriate (drug interactions, tolerability issues), or
• Patient preference after adherence counseling

If your insurer denies the prior authorization, ask your prescriber to submit a formal appeal. Denials are commonly overturned.

Apretude cost with Medicaid

Every state Medicaid program covers Apretude, though coverage specifics vary. Under the ACA preventive services mandate, PrEP — including injectable PrEP — should be covered with no cost-sharing, meaning $0 copay for the medication. Some state Medicaid plans apply small copays for the injection administration, but the drug itself is free.

Medicaid beneficiaries should note: you're not eligible for ViiV's commercial copay savings card (government insurance is excluded), but you also don't need it because Medicaid already covers the medication at $0.

Apretude cost with Medicare

Medicare Part B covers Apretude as of October 2025, when CMS finalized HCPCS J-codes for injectable PrEP. If you're enrolled in Original Medicare, Part B typically covers 80% of the approved amount after your deductible. A Medigap policy or Medicare Advantage plan can cover the remaining 20%.

Medicare beneficiaries cannot use the ViiV copay savings card (federal anti-kickback rules), but may qualify for the Good Days Foundation copay assistance program (up to $7,500/year, income limit 500% of the Federal Poverty Level).

Apretude without insurance: 3 pathways to $0

If you don't have insurance, you have three realistic paths to free or near-free Apretude. The right one depends on your income and how quickly you need coverage.

Apretude vs oral PrEP: the cost comparison

Drug	List price	Cash generic price	With assistance
Apretude (injectable)	~$24,228/yr	N/A (no generic)	$0
Yeztugo (injectable, 2x/yr)	$28,218/yr	N/A (no generic)	$0
Descovy (daily pill)	~$26,000/yr	N/A (no generic)	$0
Generic Truvada (TDF/FTC)	~$24,000/yr (brand)	~$30/mo	$0

Looking at list prices alone, Apretude and generic Truvada cost about the same annually. But with a GoodRx coupon or similar cash pricing, generic oral PrEP runs around $30–$40 per month out of pocket without any insurance or assistance at all. That's the cost floor for oral PrEP, and it's the reason insurers scrutinize Apretude prior authorizations.

If cost were the only factor, generic oral PrEP wins. But adherence matters more than price: PrEP only works if you take it consistently. For people who can't maintain daily pill adherence, injectable PrEP's 2-month dosing is often the difference between protected and unprotected — which makes the higher list price irrelevant if assistance programs bring your cost to $0.

Frequently asked questions